Coadministration of melatonin and fluoxetine does not improve the 3-month outcome following ECT

Journal of ECT

Volumn 17, Issue 2, 2001, Pages 124-128

  Grunhaus, L ^a   Hirschman, S ^a   Dolberg, O T ^a   Schreiber, S ^a   Dannon, P N ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Electroconvulsive therapy; Major depression; Manic depressive disorder; Melatonin; Outcome

Indexed keywords

FLUOXETINE; MELATONIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SINGLE BLIND PROCEDURE; SLEEP DISORDER; TREATMENT OUTCOME;

AGED; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROCONVULSIVE THERAPY; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; MELATONIN; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; TREATMENT OUTCOME;

EID: 0034970435     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200106000-00007     Document Type: Article

References (38)

1. The long-term outcome of depressive illness
2. The functioning and well-being of depressed patients, results from the medical outcomes study
3. Course of depression for adult outpatients: Results from the medical outcomes study
4. Life-time and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States: Results from the National Comorbidity Survey
5. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey
6. Delusional depression and electroconvulsive therapy: One year later
7. Continuation therapy after ECT for delusional depression: A naturalistic study of prophylactic treatments and relapse
8. Continuation therapy with antidepressants after convulsive therapy
9. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression
10. Relationship of electroconvulsive therapy to course in affective illness: A collaborative study
11. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy
12. Relapse and recurrence following a course of ECT: Reasons for concern and strategies for further investigation
13. Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention
14. Sleep electroencephalographic studies after ECT. Age and clinical response
15. Does sleep disturbance predict depression in elderly people? A study in inner London
16. Shortened REM latency post-ECT is associated with the rapid recurrence of depressive symptomatology
17. Sleep disturbance and psychiatric disorders: A longitudinal epidemiologic study of young adults
18. Melatonin in humans
19. Circadian rhythms of melatonin and cortisol in aging
20. Neuroendocrine rhythms and sleep in aging men
21. Sleep disorders and melatonin rhythms in elderly people
22. Seizure threshold in electroconvulsive therapy
23. Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar disorder
24. Neuroendocrine aspects of primary major depression. XI. Serum melatonin levels measures in patients and matched control subjects
25. A comparison of melatonin secretion in depressed patients and normal subjects
26. Nocturnal serum melatonin profile in major depression in children and adolescents
27. Melatonin, cortisol, and ACTH in patients with major depressive disorder and healthy humans with particular reference to the outcome with the dexamethasone suppression test
28. Serum melatonin levels in relation to clinical variables in patients with major depressive disorder and a new hypothesis for a low melatonin syndrome
29. The psychopharmacology of the human pineal
30. Melatonin in depression
31. Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression
32. Negative effects of melatonin in depression
33. Morning or night-time melatonin is ineffective in seasonal affective disorder
34. Effects of exogenous melatonin administration and withdrawal in five patients with rapidly-cycling bipolar disorder
35. Melatonin for the treatment of sleep disturbances in major depressive disorder
36. Biological effects of morning-plus-evening bright light treatment of SAD